Drug Design of Mitochondria-Targeted Antioxidants, Action, Metabolism and Perspectives for Ophthalmic Therapeutics: N-acetylcarnosine Codrug Treatment Platform
Journal Title: International Journal of Ophthalmology & Eye Science (IJOES) - Year 2017, Vol 5, Issue 4
Abstract
Maintaining the redox balance within the mitochondria is critical for cellular homeostasis in the eye since the mitochondria host the energy producing systems of the cell and it is widely recognized that damage to the mitochondria plays a key role in sight threatening age-related eye disorders, including retinopathies (maculodystrophy, retinitis pigmentosa , hereditary optic neuropathy), as well as glaucoma, cataract, and autoimmune uveitis. Reactive oxygen species (ROS) are generated as by-products of cellular metabolism, primarily in the mitochondria. Although ROS are essential participants in cell signaling and regulation, when their cellular production overwhelms the intrinsic antioxidant capacity, damage to cellular macromolecules such as DNA, proteins, and lipids ensues. Oxidized phospholipids play an important role in execution of the mitochondrial stage of apoptosis and clearance of apoptotic cells. During the lipid peroxidation (LPO) reaction, lipid hydroperoxides are formed as primary products. Several lines of evidence suggest that lipid hydroperoxides can trigger cell death in many cell types, which may be mediated by mitochondria dysfunction pathway. Recently, there was a breakthrough in mitochondrial targeting of antioxidants. Mitochondrial function can be manipulated selectively by targeting bioactive compounds to mitochondria in living cells. Lipophylic antioxidants were covalently coupled to a triphenylphosphonium cation, and these compounds were preferentially taken up by mitochondria. In this work we proposed the combined use of mitochondria-targeted antioxidant mito Vit E and N-acetylcarnosine, an ophthalmic prodrug of L-carnosine in patented formulation of eye drops including the mucoadhesive compound carboxymethyl cellulose to help elucidate the role of mitochondrial oxidative damage in apoptotic cell death. We suggest that mitochondrial oxidative damage plays an important role in ROS-induced apoptosis. Further work using these and other mitochondrially targeted compounds to dissect out the role of mitochondrial oxidative changes in peroxide-induced apoptosis is ongoing. The findings reported demonstrate that mitochondrially targeted antioxidants such as mito vit E + N-acetylcarnosine in the eye drop formulation with carboxymethylcellulose can be used to investigate the role of mitochondrial oxidative stress in retinal neuronal cells (RGCs) death and may represent a new pharmacologic tool to mitigate complex ocular pathology for the treatment of sight-threatening eye diseases and, especially, neurodegeneration originating from an oxidative injury and glaucomatous neurodegeneration. This strategy also has potential for unraveling the contribution of oxidative stress to other ocular pathologies involving mitochondrial dysfunction.
Authors and Affiliations
Mark A. Babizhayev
Health Coaching and Glaucoma: A Qualitative Evaluation of the Patient Experience in a Preliminary Study
Introduction: Successful medical treatment of glaucoma requires adherence to daily eye drop medications. Health coaching, which has been used successfully for other chronic diseases, may be helpful for glaucoma patients....
Anatomical Differences of Corneal Surface Parameters
Purpose: The aim of this study was to analyze possible anatomical differences of corneal surface parameters in the sample of population and between the genders. Methods: This study is presenting the sample of population...
Daylight For Healthy Indoor Environment And Energy Benefits
Daylight For Healthy Indoor Environment And Energy Benefits
Microorganisms and Common Ophthalmic Diseases
The human eye is in constant contact to environmental conditions that increase its likelihood in being exposed to a multitude of pathogens. Studies have revealed that the normal microbial flora found around the ocular ar...
Real Life Clinical Effectiveness of Razumab® (World’s First Biosimilar Ranibizumab) in Wet Age-Related Macular Degeneration: A Subgroup Analysis of Pooled Retrospective RE-ENACT Study
Background: This subgroup analysis of RE-ENACT study (retrospective, multicenter, observational pooled study on wet age-related macular degeneration [wet AMD], diabetic macular edema, and retinal vein occlusion) evaluate...